Alcoholic Liver Disease: High Risk or Low Risk for Developing Hepatocellular Carcinoma?

Clinics in Liver Disease

Volumn 20, Issue 3, 2016, Pages 563-580

  Joshi, Kartik ^a   Kohli, Anita ^a   Manch, Richard ^a   Gish, Robert ^a,b  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Alcoholic liver disease; Cirrhosis; Diabetes; Hepatitis B; Hepatitis C; Hepatocellular carcinoma risk; Obesity

Indexed keywords

ALCOHOL;

AGE; ALCOHOL ABSTINENCE; ALCOHOL LIVER DISEASE; ALCOHOLISM; CANCER RISK; COMORBIDITY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE EXACERBATION; ETHNICITY; GENOME-WIDE ASSOCIATION STUDY; HEMOCHROMATOSIS; HEPATITIS B; HEPATITIS C; HIGH RISK PATIENT; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; OBESITY; RACE; REVIEW; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; ALCOHOL LIVER CIRRHOSIS; CARCINOMA, HEPATOCELLULAR; CHRONIC HEPATITIS B; CHRONIC HEPATITIS C; COMPLICATION; DIABETES COMPLICATIONS; DRINKING BEHAVIOR; FEMALE; LIVER NEOPLASMS; MALE; RISK FACTOR;

ALCOHOL ABSTINENCE; ALCOHOL DRINKING; CARCINOMA, HEPATOCELLULAR; DIABETES COMPLICATIONS; FEMALE; HEMOCHROMATOSIS; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS, ALCOHOLIC; LIVER DISEASES, ALCOHOLIC; LIVER NEOPLASMS; MALE; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84967138063     PISSN: 10893261     EISSN: 15578224     Source Type: Journal    
DOI: 10.1016/j.cld.2016.02.012     Document Type: Review

References (67)

1. 1 Kim, W.R., Lake, J.R., Smith, J.M., et al. OPTN/SRTR 2013 annual data report: liver. Am J Transplant 15:Suppl 2 (2015), 1–28.
2. 2 El-Serag, H.B., Hepatocellular carcinoma. N Engl J Med 365:12 (2011), 1118–1127.
3. 3 Yang, J.D., Harmsen, W.S., Slettedahl, S.W., et al. Factors that affect risk for hepatocellular carcinoma and effects of surveillance. Clin Gastroenterol Hepatol 9:7 (2011), 617–623.e1.
4. 4 World Health Organization, Global status report on alcohol and health 2014. 2014, World Health Organization, Geneva (Switzerland) Available at: http://apps.who.int/iris/bitstream/10665/112736/1/9789240692763_eng.pdf Accessed August 14, 2015.
5. 5 Fattovich, G., Stroffolini, T., Zagni, I., et al. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 127:5 Suppl 1 (2004), S35–S50.
6. 6 Toshikuni, N., Izumi, A., Nishino, K., et al. Comparison of outcomes between patients with alcoholic cirrhosis and those with hepatitis C virus-related cirrhosis. J Gastroenterol Hepatol 24:7 (2009), 1276–1283.
7. 7 Jepsen, P., Ott, P., Andersen, P.K., et al. Risk for hepatocellular carcinoma in patients with alcoholic cirrhosis: a Danish nationwide cohort study. Ann Intern Med 156:12 (2012), 841–847 W295.
8. 8 Uetake, S., Yamauchi, M., Itoh, S., et al. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection. Alcohol Clin Exp Res 27:8 Suppl (2003), 47S–51S.
9. 9 N'Kontchou, G., Paries, J., Htar, M.T., et al. Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis. Clin Gastroenterol Hepatol 4:8 (2006), 1062–1068.
10. 10 Mancebo, A., Gonzalez-Dieguez, M.L., Cadahia, V., et al. Annual incidence of hepatocellular carcinoma among patients with alcoholic cirrhosis and identification of risk groups. Clin Gastroenterol Hepatol 11:1 (2013), 95–101.
11. 11 Ioannou, G.N., Splan, M.F., Weiss, N.S., et al. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol 5:8 (2007), 938–945 945.e1–4.
12. 12 Lin, C.W., Lin, C.C., Mo, L.R., et al. Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis. J Hepatol 58:4 (2013), 730–735.
13. 13 Simao, A., Madaleno, J., Silva, N., et al. Plasma osteopontin is a biomarker for the severity of alcoholic liver cirrhosis, not for hepatocellular carcinoma screening. BMC Gastroenterol, 15, 2015, 73.
14. 14 Teli, M.R., Day, C.P., Burt, A.D., et al. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet 346:8981 (1995), 987–990.
15. 15 Bagnardi, V., Blangiardo, M., La Vecchia, C., et al. A meta-analysis of alcohol drinking and cancer risk. Br J Cancer 85:11 (2001), 1700–1705.
16. 16 Savolainen, V.T., Liesto, K., Mannikko, A., et al. Alcohol consumption and alcoholic liver disease: evidence of a threshold level of effects of ethanol. Alcohol Clin Exp Res 17:5 (1993), 1112–1117.
17. 17 Bellentani, S., Saccoccio, G., Costa, G., et al. Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group. Gut 41:6 (1997), 845–850.
18. 18 Corrao, G., Bagnardi, V., Zambon, A., et al. Meta-analysis of alcohol intake in relation to risk of liver cirrhosis. Alcohol Alcohol 33:4 (1998), 381–392.
19. 19 Becker, U., Deis, A., Sorensen, T.I., et al. Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology 23:5 (1996), 1025–1029.
20. 20 Donato, F., Tagger, A., Gelatti, U., et al. Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol 155:4 (2002), 323–331.
21. 21 Rehm, J., Taylor, B., Mohapatra, S., et al. Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis. Drug Alcohol Rev 29:4 (2010), 437–445.
22. 22 Wacholder, S., Silverman, D.T., McLaughlin, J.K., et al. Selection of controls in case-control studies. II. Types of controls. Am J Epidemiol 135:9 (1992), 1029–1041.
23. 23 Lu, X.L., Luo, J.Y., Tao, M., et al. Risk factors for alcoholic liver disease in China. World J Gastroenterol 10:16 (2004), 2423–2426.
24. 24 Tsukuma, H., Hiyama, T., Tanaka, S., et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 328:25 (1993), 1797–1801.
25. 25 Heckley, G.A., Jarl, J., Asamoah, B.O., et al. How the risk of liver cancer changes after alcohol cessation: a review and meta-analysis of the current literature. BMC Cancer, 11, 2011, 446.
26. 26 Pares, A., Caballeria, J., Bruguera, M., et al. Histological course of alcoholic hepatitis. Influence of abstinence, sex and extent of hepatic damage. J Hepatol 2:1 (1986), 33–42.
27. 27 Poynard, T., Mathurin, P., Lai, C.L., et al. A comparison of fibrosis progression in chronic liver diseases. J Hepatol 38:3 (2003), 257–265.
28. 28 Baraona, E., Abittan, C.S., Dohmen, K., et al. Gender differences in pharmacokinetics of alcohol. Alcohol Clin Exp Res 25:4 (2001), 502–507.
29. 29 Frezza, M., di Padova, C., Pozzato, G., et al. High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. N Engl J Med 322:2 (1990), 95–99.
30. 30 Marshall, A.W., Kingstone, D., Boss, M., et al. Ethanol elimination in males and females: relationship to menstrual cycle and body composition. Hepatology 3:5 (1983), 701–706.
31. 31 Gavaler, J.S., Alcohol effects on hormone levels in normal postmenopausal women and in postmenopausal women with alcohol-induced cirrhosis. Recent Dev Alcohol 12 (1995), 199–208.
32. 32 Ikejima, K., Enomoto, N., Iimuro, Y., et al. Estrogen increases sensitivity of hepatic Kupffer cells to endotoxin. Am J Physiol 274:4 Pt 1 (1998), G669–G676.
33. 33 Thurman, R.G., Sex-related liver injury due to alcohol involves activation of Kupffer cells by endotoxin. Can J Gastroenterol 14:Suppl D (2000), 129D–135D.
34. 34 Yin, M., Ikejima, K., Wheeler, M.D., et al. Estrogen is involved in early alcohol-induced liver injury in a rat enteral feeding model. Hepatology 31:1 (2000), 117–123.
35. 35 Douds, A.C., Cox, M.A., Iqbal, T.H., et al. Ethnic differences in cirrhosis of the liver in a British city: alcoholic cirrhosis in South Asian men. Alcohol Alcohol 38:2 (2003), 148–150.
36. 36 Cochrane, R., Bal, S., The drinking habits of Sikh, Hindu, Muslim and white men in the West Midlands: a community survey. Br J Addict 85:6 (1990), 759–769.
37. 37 Hassan, M.M., Hwang, L.Y., Hatten, C.J., et al. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 36:5 (2002), 1206–1213.
38. 38 Chung, N.S., Kwon, O.S., Park, C.H., et al. A comparative cross-sectional study of the development of hepatocellular carcinoma in patients with liver cirrhosis caused by hepatitis B virus, alcohol, or combination of hepatitis b virus and alcohol. Korean J Gastroenterol 49:6 (2007), 369–375 [in Korean].
39. 39 Wang, L.Y., You, S.L., Lu, S.N., et al. Risk of hepatocellular carcinoma and habits of alcohol drinking, betel quid chewing and cigarette smoking: a cohort of 2416 HBsAg-seropositive and 9421 HBsAg-seronegative male residents in Taiwan. Cancer Causes Control 14:3 (2003), 241–250.
40. 40 Gish, R.G., Given, B.D., Lai, C.L., et al. Chronic hepatitis B: virology, natural history, current management and a glimpse at future opportunities. Antiviral Res 121 (2015), 47–58.
41. 41 Kwon, O.S., Jung, Y.K., Bae, K.S., et al. Anti-hepatitis B core positivity as a risk factor for hepatocellular carcinoma in alcoholic cirrhosis: a case-control study. Alcohol 46:6 (2012), 537–541.
42. 42 Poynard, T., Bedossa, P., Opolon, P., Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 349:9055 (1997), 825–832.
43. 43 Wiley, T.E., McCarthy, M., Breidi, L., et al. Impact of alcohol on the histological and clinical progression of hepatitis C infection. Hepatology 28:3 (1998), 805–809.
44. 44 Aizawa, Y., Shibamoto, Y., Takagi, I., et al. Analysis of factors affecting the appearance of hepatocellular carcinoma in patients with chronic hepatitis C. A long term follow-up study after histologic diagnosis. Cancer 89:1 (2000), 53–59.
45. 45 Ikeda, K., Saitoh, S., Koida, I., et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 18:1 (1993), 47–53.
46. 46 Tagger, A., Donato, F., Ribero, M.L., et al. Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: the role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Brescia HCC Study. Int J Cancer 81:5 (1999), 695–699.
47. 47 Tsutsumi, M., Ishizaki, M., Takada, A., Relative risk for the development of hepatocellular carcinoma in alcoholic patients with cirrhosis: a multiple logistic-regression coefficient analysis. Alcohol Clin Exp Res 20:4 (1996), 758–762.
48. 48 Scotet, V., Merour, M.C., Mercier, A.Y., et al. Hereditary hemochromatosis: effect of excessive alcohol consumption on disease expression in patients homozygous for the C282Y mutation. Am J Epidemiol 158:2 (2003), 129–134.
49. 49 Fletcher, L.M., Dixon, J.L., Purdie, D.M., et al. Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis. Gastroenterology 122:2 (2002), 281–289.
50. 50 Salameh, H., Raff, E., Erwin, A., et al. PNPLA3 gene polymorphism is associated with predisposition to and severity of alcoholic liver disease. Am J Gastroenterol 110:6 (2015), 846–856.
51. 51 Trepo, E., Nahon, P., Bontempi, G., et al. Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: evidence from a meta-analysis of individual participant data. Hepatology 59:6 (2014), 2170–2177.
52. 52 Machado, M.V., Cortez-Pinto, H., Proangiogenic factors in the development of HCC in alcoholic cirrhosis. Clin Res Hepatol Gastroenterol 39:Suppl 1 (2015), S104–S108.
53. 53 Machado, M.V., Janeiro, A., Miltenberger-Miltenyi, G., et al. Genetic polymorphisms of proangiogenic factors seem to favor hepatocellular carcinoma development in alcoholic cirrhosis. Eur J Gastroenterol Hepatol 26:4 (2014), 438–443.
54. 54 Druesne-Pecollo, N., Tehard, B., Mallet, Y., et al. Alcohol and genetic polymorphisms: effect on risk of alcohol-related cancer. Lancet Oncol 10:2 (2009), 173–180.
55. 55 He, L., Deng, T., Luo, H.S., Alcohol dehydrogenase 1C (ADH1C) gene polymorphism and alcoholic liver cirrhosis risk: a meta analysis. Int J Clin Exp Med 8:7 (2015), 11117–11124.
56. 56 Zintzaras, E., Stefanidis, I., Santos, M., et al. Do alcohol-metabolizing enzyme gene polymorphisms increase the risk of alcoholism and alcoholic liver disease?. Hepatology 43:2 (2006), 352–361.
57. 57 Nahon, P., Sutton, A., Rufat, P., et al. Myeloperoxidase and superoxide dismutase 2 polymorphisms comodulate the risk of hepatocellular carcinoma and death in alcoholic cirrhosis. Hepatology 50:5 (2009), 1484–1493.
58. 58 Saffroy, R., Pham, P., Chiappini, F., et al. The MTHFR 677C T polymorphism is associated with an increased risk of hepatocellular carcinoma in patients with alcoholic cirrhosis. Carcinogenesis 25:8 (2004), 1443–1448.
59. 59 El-Serag, H.B., Hampel, H., Javadi, F., The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol 4:3 (2006), 369–380.
60. 60 Wang, C., Wang, X., Gong, G., et al. Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies. Int J Cancer 130:7 (2012), 1639–1648.
61. 61 Chen, J., Han, Y., Xu, C., et al. Effect of type 2 diabetes mellitus on the risk for hepatocellular carcinoma in chronic liver diseases: a meta-analysis of cohort studies. Eur J Cancer Prev 24:2 (2015), 89–99.
62. 62 Torisu, Y., Ikeda, K., Kobayashi, M., et al. Diabetes mellitus increases the risk of hepatocarcinogenesis in patients with alcoholic cirrhosis: a preliminary report. Hepatol Res 37:7 (2007), 517–523.
63. 63 Yuan, J.M., Govindarajan, S., Arakawa, K., et al. Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S. Cancer 101:5 (2004), 1009–1017.
64. 64 Archambeaud, I., Auble, H., Nahon, P., et al. Risk factors for hepatocellular carcinoma in Caucasian patients with non-viral cirrhosis: the importance of prior obesity. Liver Int 35:7 (2015), 1872–1876.
65. 65 Loomba, R., Yang, H.I., Su, J., et al. Obesity and alcohol synergize to increase the risk of incident hepatocellular carcinoma in men. Clin Gastroenterol Hepatol 8:10 (2010), 891–898 898.e1–2.
66. 66 Marrero, J.A., Fontana, R.J., Fu, S., et al. Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol 42:2 (2005), 218–224.
67. 67 Miyakawa, H., Sato, C., Izumi, N., et al. Hepatitis C virus infection and alcoholic liver cirrhosis in Japan: its contribution to the development of hepatocellular carcinoma. Alcohol Alcohol Suppl 1A (1993), 85–90.